Showing posts with label state stem cell research. Show all posts
Showing posts with label state stem cell research. Show all posts

Tuesday, August 21, 2007

More Adding Up on Private Funding for Stem Cell Research

Attorney Ken Taymor. executive director of the Berkeley Center for Law, Business and the Economy at UC Berkeley, sends the following re our earlier item about state and private funding for stem cell research.

Thanks for bringing James Fossett's excellent report to our attention. A very, very quick search online raises questions about the accuracy of the calculation of private support for stem cell research in California (really a nit, but worth clarifying; I don't think it goes to the heart of his insights). At least three other major gifts have been reported in the press - excerpted below with URLs. In addition, as the report does note, the Show Me state is showing the Stowers the door, so while the money is coming from Missouri, it appears that it will be spent everywhere but Missouri. The news reports on donations in California of which I am aware are as follows:

"Sound pioneer Ray Dolby and his wife gave $16 million to the University of California, San Francisco to start a stem cell center that will perform research without federal funds."

http://sfgate.com/cgi-bin/article.cgi?f=/n/a/2006/05/10/financial/f224444D16.DTL

"USC announced it has received $25 million from the Broad Foundation to create the Broad Institute for Integrative Biology and Stem Cell Research at the Keck School of Medicine of USC."

http://www.usc.edu/uscnews/stories/12093.html

"Without seeing a dime of this [Prop 71] money, numerous California universities and research institutes already have committed to expanding their stem cell research programs, often with help from private donors. They are doing it with the help of philanthropists, who have given more than $250 million to California universities and research programs since 2005, Klein said. Those donations include a $20 million gift to the Stanford University Medical School from the New York-based Virginia and D.K. Ludwig Fund. The money from the fund, which is known for its support of cancer research, allows the school to establish a stem cell research center."

http://www.signonsandiego.com/news/business/biotech/20061219-9999-lz1n19stem.html

Friday, January 05, 2007

The California Poster Child, Stem Cell Wars and Proverbial Church Picnics

Are states running amok with embryonic stem cell research? Should or can the federal government reassert its control? Can workable compromises be found?

Richard Hayes, executive director of the Center for Genetics and Society in Oakland, Ca., addresses these issues in a piece on Bioethics Forum, which is sponsored by the Hastings Center Report.

Hayes writes about the "sorry" state of the stem cell debate:
"This polarized politics has given us the worst of all possible worlds: a policy stalemate at the federal level accompanied by a plethora of state-level stem cell funding programs lacking the sort of planning, ethical oversight, and regulation that biomedical research of such consequence requires. California's $3 billion stem cell program is the poster child of this predicament. Since its inception in 2004 it has been under fire for conflicts of interest, inadequate concern for the health and safety of women who provide eggs for stem cell research, unrepresentative policy-making bodies, and misplaced research priorities.

"These flawed state programs are setting the stage for even greater problems to come. Technologies now under development, including pre-implantation genetic diagnosis for both medical conditions and cosmetic traits, somatic genetic enhancement, and inheritable genetic modification, promise to make the stem cell wars look like the proverbial church picnic.

"If these technologies are embraced by the largely unaccountable infrastructure now being established to support stem cell research, they will be difficult to constrain. Once developed and made commercially available, they would be used disproportionately by the most privileged, and become new and powerful drivers of inequality and exclusion.

"The tragedy of this situation is that public opinion surveys consistently show that a strong majority of Americans support a morally serious middle ground regarding the new human genetic technologies. Americans are not irrevocably opposed to research involving the destruction of human embryos, but they want to make sure it is done only after alternatives have been exhausted, and with effective structures of public oversight in place. Americans want cures for diseases, but few are willing to turn the genetic future of the human species over to dismissively arrogant scientists and profit-hungry biotech boosters. Unfortunately, no organized constituencies with influence comparable to that of the religious conservatives or the research/patient/bioindustrial community exist to represent this majoritarian position in the political arena."
Hayes finds some hope in the approach detailed in "Beyond Bioethics: A Proposal for Modernizing the Regulation of Human Biotechnologies," by Francis Fukuyama and Franco Furger. Hayes said the book "could serve as a rallying point for those desiring an end to the current counterproductive policy stalemate."

Hayes called the book "the most comprehensive analysis of human biotech regulatory policy yet published in the United States. With the 2008 congressional and presidential campaigns now moving into high gear, the report comes at an opportune time. "Beyond Bioethics" should be studied carefully by everyone interested in working towards human biotech policies that can be supported by the great majority of Americans."

Search This Blog